Citation: G. Edelstam et al., FIBRINOLYSIS IN THE PERITONEAL-FLUID DURING ADHESIONS, ENDOMETRIOSIS AND ONGOING PELVIC INFLAMMATORY DISEASE, Inflammation, 22(4), 1998, pp. 341-351
Authors:
BORGFELDT C
CASSLEN B
LIU CL
HANSSON S
LECANDER I
ASTEDT B
Citation: C. Borgfeldt et al., HIGH TISSUE CONTENT OF UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IS ASSOCIATED WITH HIGH STROMAL EXPRESSION OF U-PA MESSENGER-RNA IN POORLY DIFFERENTIATED SEROUS OVARIAN-CARCINOMA, International journal of cancer, 79(6), 1998, pp. 588-595
Authors:
BRUSE C
BERGQVIST A
CARLSTROM K
FIANUJONASSON A
LECANDER I
ASTEDT B
Citation: C. Bruse et al., FIBRINOLYTIC FACTORS IN ENDOMETRIOTIC TISSUE, ENDOMETRIUM, PERITONEAL-FLUID, AND PLASMA FROM WOMEN WITH ENDOMETRIOSIS AND IN ENDOMETRIUM AND PERITONEAL-FLUID FROM HEALTHY WOMEN, Fertility and sterility, 70(5), 1998, pp. 821-826
Authors:
LINDOFF C
PETERSON F
LECANDER I
MARTINSSON G
ASTEDT B
Citation: C. Lindoff et al., TRANSDERMAL ESTROGEN REPLACEMENT THERAPY - BENEFICIAL-EFFECTS ON HEMOSTATIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE, Maturitas, 24(1-2), 1996, pp. 43-50
Citation: A. Billstrom et al., PRODUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN HUMAN PERIPHERAL-BLOOD MONOCYTES UP-REGULATED IN-VITRO BY THE QUINOLINE-3-CARBOXAMIDE, LINOMIDE, Fibrinolysis, 10(5-6), 1996, pp. 277-283
Citation: J. Nordengren et al., PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS, Fibrinolysis, 10(5-6), 1996, pp. 295-302
Authors:
ASTEDT B
LECANDER I
MARTINSSON G
KISO U
HENSCHEN A
Citation: B. Astedt et al., ON THE AFFINITY BETWEEN THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 AND APOLIPOPROTEIN A(1), Scandinavian journal of clinical & laboratory investigation, 56(6), 1996, pp. 491-496
Authors:
BILLSTROM A
LECANDER I
DAGNAESHANSEN F
DAHLLOF B
STENRAM U
HARTLEYASP B
Citation: A. Billstrom et al., DIFFERENTIAL EXPRESSION OF UPA IN AN AGGRESSIVE (DU-145) AND A NONAGGRESSIVE (1013L) HUMAN PROSTATE-CANCER XENOGRAFT, The Prostate, 26(2), 1995, pp. 94-104
Authors:
ANDOLF E
CASSLEN B
JORGENSEN C
BUCHHAVE P
LECANDER I
Citation: E. Andolf et al., FLUID CHARACTERISTICS OF BENIGN OVARIAN CYSTS - CORRELATION WITH RECURRENCE AFTER PUNCTURE, Obstetrics and gynecology, 86(4), 1995, pp. 529-535
Authors:
BILLSTROM A
HARTLEYASP B
LECANDER I
BATRA S
ASTEDT B
Citation: A. Billstrom et al., THE UROKINASE INHIBITOR P-AMINOBENZAMIDINE INHIBITS GROWTH OF A HUMANPROSTATE TUMOR IN SCID MICE, International journal of cancer, 61(4), 1995, pp. 542-547
Citation: B. Casslen et al., PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN BLOOD AND TUMOR FLUIDS OF PATIENTS WITH OVARIAN-CANCER, European journal of cancer, 30A(9), 1994, pp. 1302-1309
Citation: B. Kinnby et al., THE PLASMINOGEN-ACTIVATING SYSTEM IN GINGIVAL FLUID FROM ADULTS - AN INTRAINDIVIDUAL STUDY BEFORE AND AFTER TREATMENT OF GINGIVITIS, Scandinavian Journal of Dental Research, 102(6), 1994, pp. 334-341
Authors:
ASTEDT B
CASSLEN B
LECANDER I
NILSSON L
NORGREN L
Citation: B. Astedt et al., REBOUND INCREASE OF PAI-1 FOLLOWING LOCAL INTRAARTERIAL RT-PA INFUSION, A POSSIBLE CAUSE OF REOCCLUSION, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 563-567
Citation: C. Lindoff et al., FIBRINOLYTIC COMPONENTS IN INDIVIDUAL CONSECUTIVE PLASMA SAMPLES DURING NORMAL-PREGNANCY, Fibrinolysis, 7(3), 1993, pp. 190-194
Authors:
KINNBY B
BORGSTROM MK
GRANATH L
LECANDER I
SUNDIN B
Citation: B. Kinnby et al., TISSUE-PLASMINOGEN ACTIVATOR (T-PA) AND PLACENTAL PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-2) IN GINGIVAL FLUID FROM 8-9-YEAR-OLD CHILDREN, Scandinavian Journal of Dental Research, 101(5), 1993, pp. 279-281